Halberd Corporation

Dec 1 2020

Halberd Corporation Advisory Board Reorganization Announced

By |2020-11-30T19:45:04-05:00December 1st, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, December 1, 2020 – Halberd Corp. (OTC PINK: "HALB") announces the reorganization of its Scientific Advisory Board.  The new Advisory Board will consist of two sub-boards: a multi-disciplined Scientific Advisory Board focused on biomedical issues and a Business Advisory Board focusing on business issues.  The two boards will interface on a regular ...

Read More
Nov 25 2020

Halberd Corp. CEO Interviewed on Money TV;
Discusses 2020 Accomplishments and Plans

By |2020-11-24T20:59:01-05:00November 25th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, November 25, 2020 – Halberd Corporation (OTC-PINK: "HALB") Chairman, President and CEO, William A. Hartman, was interviewed this week by host, Donald Baillargeon, on Money TV.  Mr. Hartman recapped the company’s accomplishments, describing its most promising technologies and described the unique applications perceived, including a sneak peek at the future. Mr. Hartman ...

Read More
INVESTOR/MEDIA INQUIRIES

MEDICAL METAVERSE

As part of our efforts to remain at the forefront of breakthrough technologies in the medical and scientific fields, Halberd Corporation is engaged in scientific study and research in the fields of medicine, the prevention, treatment and management of illness and infections and rapid tests to identify infection, and other medical maladies.

To learn more about how we can further your efforts, or to partner with Halberd on specific healthcare solutions, please email: info@halberdcorporation.com

© Copyright 2019 - | Halberd Corporation | All Rights Reserved
XEmail
Go to Top